Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) Inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025

"Increasing growth in the pharmaceutical drug market is expected to drive the growth of the pharmaceutical excipients market."

The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%. The growth in this market can be attributed to factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals. However, certain barriers, such as the increasing regulatory stringency and the cost and time-intensive drug development process are expected to restrain the growth of this market to a certain extent during the forecast period.

"Organic chemicals segment to dominate the pharmaceutical excipients market in 2019."

Based on product, the pharmaceutical excipients market is segmented into three major categories- organic chemicals, inorganic chemicals, and other chemicals. In 2018, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in the majority of pharmaceutical formulations available in the pharmaceutical market. Also, the organic chemicals market had the highest CAGR above all.

"Advantages of topical drug delivery are driving demand for excipients in this segment."

Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. Currently, there is a growing focus on the use of liposomes for the delivery of topical drugs. With this, there is a growing need for developing novel excipients that can improve the solubility and functionality of such formulations. Growth in this market segment is expected to play a major role in the growth of the pharmaceutical excipients market for topical formulations in the coming years.

"Europe accounted for the largest share of the market in 2018, whereas the Asia Pacific was the fastest growing market."

The pharmaceutical excipients market is broadly divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe accounted for the largest share of the global pharmaceutical excipients market. The large share of this region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to high consumption of excipients. However, the Asia Pacific region is expected to be the fastest growing market. The factors driving the growth of this region can be attributed to the increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations -CMOs, rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor & manufacturing costs, and the large base for the generation of generics & biologics. The Asia Pacific market is expected to have the highest CAGR during the forecast period.

The breakup of primary participants is as mentioned below:

• By Company Type: Tier 1 - 48%, Tier 2 - 34%, and Tier 3 - 18%

• By Designation: C-level - 42%, Director-level - 36%, and Others - 22%

• By Region: Europe - 38%, North America - 34%, Asia Pacific - 17%, South America -7%, and the Middle East and Africa - 4%

The prominent players in the global pharmaceutical excipients market are: Ashland Global Holdings, Inc. -US, BASF SE -Germany, DuPont de Nemours, Inc. -US, Roquette -France, Evonik Industries AG -Germany, Associated British Foods -UK, Archer Daniels Midland Company -US, Lubrizol Corporation -US, and Croda International -UK. Other players in this market are Innophos Holdings -US, Kerry Group -Ireland, WACKER Chemie AG -Germany, Colorcon -US, DFE Pharma -Germany, JRS Pharma -Germany, and Air Liquide S.A -France.

Research Coverage:

The report analyzes the pharmaceutical excipients market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, functionality, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the global pharmaceutical excipients market. The report analyzes this market by product, functionality, formulation, and region

• Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global pharmaceutical excipients market

• Market Development: Comprehensive information on the lucrative emerging markets by product, functionality, formulation, and region

• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pharmaceutical excipients market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global pharmaceutical excipients market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED FOR THE STUDY
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of Primaries
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 DATA TRIANGULATION APPROACH
• 2.4 MARKET SHARE ESTIMATION
• 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
• 4.2 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.3 REGIONAL MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2019-2025)
• 4.4 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION (2018)
• 4.5 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 MARKET DRIVERS
    • 5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients
    • 5.2.1.2 Surge in the generics market
    • 5.2.1.3 Increasing uptake of biopharmaceuticals
    • 5.2.1.4 Rising adoption of orphan drugs
  • 5.2.2 MARKET RESTRAINTS
    • 5.2.2.1 Cost and time-intensive drug development process
    • 5.2.2.2 Increasing regulatory stringency
  • 5.2.3 MARKET OPPORTUNITIES
    • 5.2.3.1 Multifunctional excipients
    • 5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
    • 5.2.3.3 Growth in the biosimilars market
  • 5.2.4 MARKET CHALLENGES
    • 5.2.4.1 Safety and quality concerns
    • 5.2.4.2 Changing trade policies between countries

6 INDUSTRY INSIGHTS

• 6.1 INTRODUCTION
• 6.2 INDUSTRY TRENDS
  • 6.2.1 RISING DEMAND AND EMPHASIS ON CO-PROCESSED EXCIPIENTS
  • 6.2.2 IMPROVING EXCIPIENT CAPABILITIES BY USING NANOTECHNOLOGY
  • 6.2.3 INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS
  • 6.2.4 PHARMACEUTICAL EXCIPIENTS INFLUENCING THE COST OF PRODUCTION
• 6.3 REGULATORY ANALYSIS
  • 6.3.1 NORTH AMERICA
    • 6.3.1.1 US
    • 6.3.1.2 Canada
  • 6.3.2 EUROPE
  • 6.3.3 ASIA PACIFIC
    • 6.3.3.1 Japan
    • 6.3.3.2 China
    • 6.3.3.3 India

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

• 7.1 INTRODUCTION
• 7.2 ORGANIC CHEMICALS
  • 7.2.1 OLEOCHEMICALS
    • 7.2.1.1 Fatty alcohols
      • 7.2.1.1.1 Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature-a major driver for market growth
    • 7.2.1.2 Mineral stearates
      • 7.2.1.2.1 Market growth is due to the wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations
    • 7.2.1.3 Glycerin
      • 7.2.1.3.1 The extensive applications of glycerine are expected to drive growth in this market segment
    • 7.2.1.4 Other oleochemicals
  • 7.2.2 CARBOHYDRATES
    • 7.2.2.1 Sugars
      • 7.2.2.1.1 Actual sugars
      • 7.2.2.1.1.1 Lactose
      • 7.2.2.1.1.1.1 Being the most commonly used excipient in tablets and capsules, lactose captures a major share of the actual sugars market
      • 7.2.2.1.1.2 Sucrose
      • 7.2.2.1.1.2.1 Sucrose is extensively used in oral pharmaceutical formulations-a major factor driving market growth
      • 7.2.2.1.1.3 Dextrose (D-Glucose)
      • 7.2.2.1.1.3.1 Dextrose has a wide range of applications in tablets and capsules, which is a primary driver for adoption
      • 7.2.2.1.2 Sugar alcohols
      • 7.2.2.1.2.1 Mannitol
      • 7.2.2.1.2.1.1 Mannitol is widely used with moisture-sensitive active ingredients as it is non-hygroscopic in nature; this is a major factor driving the adoption of this product
      • 7.2.2.1.2.2 Sorbitol
      • 7.2.2.1.2.2.1 Sorbitol is one of the most widely used compression diluents for pharmaceutical formulations owing to its various advantages
      • 7.2.2.1.2.3 Other sugar alcohols
      • 7.2.2.1.3 Artificial sweeteners
      • 7.2.2.1.3.1 Gradual increase in utilization of artificial sweeteners due to regulatory acceptibility is expected to drive this market
    • 7.2.2.2 Cellulose
      • 7.2.2.2.1 Microcrystalline cellulose
      • 7.2.2.2.1.1 Its highly compressible nature makes microcrystalline cellulose the most widely used excipient in the direct compression method for tablets
      • 7.2.2.2.2 Cellulose ethers
      • 7.2.2.2.2.1 Cellulose ethers are the most widely available polymers in nature, which is a major driving factor
      • 7.2.2.2.3 CMC and croscarmellose sodium
      • 7.2.2.2.3.1 The multiple advantages of CMC and croscarmellose sodium make them the most widely used binders, glidants, anti-adherents, and suspending agents in injectable preparations
      • 7.2.2.2.4 Cellulose esters
      • 7.2.2.2.4.1 Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix, which increases the demand for these substances
    • 7.2.2.3 Starch
      • 7.2.2.3.1 Modified starch
      • 7.2.2.3.1.1 Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities
      • 7.2.2.3.2 Dried starch
      • 7.2.2.3.2.1 Dried starch is a strong binding and coating agent, factors boosting adoption
      • 7.2.2.3.3 Converted starch
      • 7.2.2.3.3.1 Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs
  • 7.2.3 PETROCHEMICALS
    • 7.2.3.1 Glycols
      • 7.2.3.1.1 Polyethylene glycol
      • 7.2.3.1.1.1 PEG is the excipient of choice in a large number of drug formulations due to its tunable properties and well-established safety profile
      • 7.2.3.1.2 Propylene glycol
      • 7.2.3.1.2.1 In high amounts, propylene glycol has been reported to be toxic among the pediatric population, which could be a restraining factor for market growth
    • 7.2.3.2 Povidones
      • 7.2.3.2.1 Rising demand for fast-dissolving tablets is expected to propel the market for povidones
    • 7.2.3.3 Mineral hydrocarbons
      • 7.2.3.3.1 Petrolatum
      • 7.2.3.3.1.1 Increasing treatment rates for psoriasis, pruritus, eczema, and acne are driving the dermatology market, which in turn is expected to drive the growth of the petrolatum market
      • 7.2.3.3.2 Mineral waxes
      • 7.2.3.3.2.1 Being non-toxic and non-irritant by nature, they are most suitable for skin and eye preparations
      • 7.2.3.3.3 Mineral oils
      • 7.2.3.3.3.1 White mineral oils are good emollients, lubricating agents, and solvents, owing to which they are widely used in ointments
    • 7.2.3.4 Acrylic polymers
      • 7.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive the growth of this market
    • 7.2.3.5 Other petrochemicals
  • 7.2.4 PROTEINS
    • 7.2.4.1 Rising application of proteins as carriers for microparticles and nanoparticles to drive this market
  • 7.2.5 OTHER ORGANIC CHEMICALS
• 7.3 INORGANIC CHEMICALS
  • 7.3.1 CALCIUM PHOSPHATE
    • 7.3.1.1 Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry
  • 7.3.2 METAL OXIDES
    • 7.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth
  • 7.3.3 HALITES
    • 7.3.3.1 Increased utilization of halites in vaccines as well as controlled-release formulations is driving their demand in the market
  • 7.3.4 CALCIUM CARBONATE
    • 7.3.4.1 Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market
  • 7.3.5 CALCIUM SULFATE
    • 7.3.5.1 Calcium sulfate is a cost-effective, quality enhancing diluent for solid dosage forms
  • 7.3.6 OTHER INORGANIC CHEMICALS
• 7.4 OTHER CHEMICALS

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

• 8.1 INTRODUCTION
• 8.2 FILLERS & DILUENTS
  • 8.2.1 DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN TABLETS
• 8.3 SUSPENDING & VISCOSITY AGENTS
  • 8.3.1 SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY, MASKED TASTE OF INSOLUBLE INGREDIENTS, AND PROLONGED DRUG ACTION
• 8.4 COATING AGENTS
  • 8.4.1 THE INCREASING UTILIZATION OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMACEUTICAL INDUSTRY IS DRIVING THIS MARKET SEGMENT
• 8.5 BINDERS
  • 8.5.1 BINDERS PROVIDE THE PROPERTIES OF FLUIDITY AND COMPRESSIBILITY THAT ARE ESSENTIAL FOR TABLET MANUFACTURING
• 8.6 FLAVORING AGENTS & SWEETENERS
  • 8.6.1 FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS
• 8.7 DISINTEGRANTS
  • 8.7.1 DISINTEGRANTS ALLOW TABLETS AND CAPSULES TO PACK A POWERFUL PORTION OF MEDICATIONS IN A SMALL FORM THAT IS EASIER TO INGEST
• 8.8 COLORANTS
  • 8.8.1 COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS
• 8.9 LUBRICANTS & GLIDANTS
  • 8.9.1 GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTERPARTICLE FRICTION AND COHESION
• 8.10 PRESERVATIVES
  • 8.10.1 BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY
• 8.11 EMULSIFYING AGENTS
  • 8.11.1 THE USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE THE BIOAVAILABILITY OF THE API
• 8.12 OTHER FUNCTIONALITIES

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION

• 9.1 INTRODUCTION
• 9.2 ORAL FORMULATIONS
  • 9.2.1 TABLETS
    • 9.2.1.1 Tablets are the most widely used dosage forms; this is a major contributing factor to market growth
  • 9.2.2 CAPSULES
    • 9.2.2.1 Hard gelatin capsules
      • 9.2.2.1.1 The ease of manufacturing of hard gelatin capsules and the versatility of this dosage form are among the major factors driving the growth of the hard gelatin capsules market
    • 9.2.2.2 Soft gelatin capsules
      • 9.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis have been reported with the use of soft gels, which are restricting factors for market growth
  • 9.2.3 LIQUID FORMULATIONS
    • 9.2.3.1 No dissolution time and rapid absorption from stomach compare to tablet
• 9.3 TOPICAL FORMULATIONS
  • 9.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING DEMAND FOR EXCIPIENTS IN THIS SEGMENT
• 9.4 PARENTERAL FORMULATIONS
  • 9.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE THE DEMAND FOR EXCIPIENTS
• 9.5 OTHER FORMULATIONS

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 EUROPE
  • 10.2.1 GERMANY
    • 10.2.1.1 Germany accounted for the largest share of the market in 2018
  • 10.2.2 FRANCE
    • 10.2.2.1 Stringent policies to support innovation pose regulatory challenges for the pharmaceutical excipients market in France
  • 10.2.3 UK
    • 10.2.3.1 Growing adoption of generics and the development of novel multi-functional co-processed excipients to drive market growth
  • 10.2.4 SWITZERLAND
    • 10.2.4.1 Large volume of pharmaceuticals produced in Switzerland provides huge potential for the utilization of pharmaceutical excipients
  • 10.2.5 ITALY
    • 10.2.5.1 Budgetary constraints and restricted healthcare spending to impede the growth of the Italian market
  • 10.2.6 SPAIN
    • 10.2.6.1 High consumption of biologics to support market growth
  • 10.2.7 REST OF EUROPE
• 10.3 NORTH AMERICA
  • 10.3.1 US
    • 10.3.1.1 The US dominates the North American market due to the increasing use of biologics and the increasing per capita pharmaceutical spending
  • 10.3.2 CANADA
    • 10.3.2.1 Strong growth of the emerging markets and slowdown in new product approvals to hamper market growth in Canada
• 10.4 ASIA PACIFIC
  • 10.4.1 JAPAN
    • 10.4.1.1 Rapid growth of Japan's geriatric population will greatly drive the demand for pharmaceuticals
  • 10.4.2 CHINA
    • 10.4.2.1 Chinese government has emphasized generics and off-patent drugs
  • 10.4.3 INDIA
    • 10.4.3.1 India is a leading producer of generics
  • 10.4.4 SOUTH KOREA
    • 10.4.4.1 Thriving generic drug market to support the growth of pharmaceutical excipients market in South Korea
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH
• 10.6 MIDDLE EAST AND AFRICA
  • 10.6.1 UNSATURATED MARKETS IN THIS REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
• 11.3 COMPETITIVE LEADERSHIP MAPPING
  • 11.3.1 VISIONARY LEADERS
  • 11.3.2 INNOVATORS
  • 11.3.3 DYNAMIC DIFFERENTIATORS
  • 11.3.4 EMERGING COMPANIES
• 11.4 MARKET SHARE ANALYSIS
  • 11.4.1 PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2018
• 11.5 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE
• 11.6 COMPETITIVE SITUATIONS AND TRENDS

12 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view, SWOT analysis)*

• 12.1 DUPONT DE NEMOURS, INC.
• 12.2 ROQUETTE FRERES
• 12.3 ASHLAND GLOBAL HOLDINGS INC.
• 12.4 EVONIK INDUSTRIES AG
• 12.5 BASF SE
• 12.6 KERRY GROUP PLC
• 12.7 CRODA INTERNATIONAL
• 12.8 ASSOCIATED BRITISH FOODS PLC
• 12.9 ARCHER DANIELS MIDLAND COMPANY
• 12.10 LUBRIZOL CORPORATION
• 12.11 INNOPHOS HOLDINGS INC.
• 12.12 WACKER CHEMIE AG
• 12.13 AIR LIQUIDE S.A.
• 12.14 COLORCON INC.
• 12.15 DMV-FONTERRA EXCIPIENTS GMBH & CO. KG
• 12.16 JRS PHARMA GMBH & CO. KG

Business overview, Products offered, Recent developments, MNM view, SWOT analysis might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 INSIGHTS OF INDUSTRY EXPERTS
• 13.2 MARKET SIZING & VALIDATION APPROACH
• 13.3 DISCUSSION GUIDE
• 13.4 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.5 AVAILABLE CUSTOMIZATIONS
• 13.6 RELATED REPORTS
• 13.7 AUTHOR DETAILS

LIST OF TABLES

• TABLE 1: DRUGS COMING OFF-PATENT
• TABLE 2: KEY MARKET DRIVERS: IMPACT ANALYSIS
• TABLE 3: KEY MARKET RESTRAINTS: IMPACT ANALYSIS
• TABLE 4: MULTIFUNCTIONAL EXCIPIENTS
• TABLE 5: CLINICAL STUDIES FOR BIOLOGICS & BIOSIMILARS (2017)
• TABLE 6: KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
• TABLE 7: KEY MARKET CHALLENGES: IMPACT ANALYSIS
• TABLE 8: MARKETED CO-PROCESSED EXCIPIENTS
• TABLE 9: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 10: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 11: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 12: ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 13: OLEOCHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 14: OLEOCHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 15: OLEOCHEMICALS: KEY BRANDS
• TABLE 16: FATTY ALCOHOLS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 17: MINERAL STEARATES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 18: GLYCERIN MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 19: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 20: CARBOHYDRATES MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 21: CARBOHYDRATES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 22: CARBOHYDRATES: KEY BRANDS
• TABLE 23: SUGARS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 24: SUGARS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 25: ACTUAL SUGARS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 26: ACTUAL SUGARS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 27: SUGAR ALCOHOLS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 28: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 29: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 30: CELLULOSE MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 31: CELLULOSE MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 32: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 33: CELLULOSE ETHERS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 34: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 35: CELLULOSE ESTERS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 36: STARCH MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 37: STARCH MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 38: MODIFIED STARCH MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 39: DRIED STARCH MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 40: CONVERTED STARCH MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 41: PETROCHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 42: PETROCHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 43: PETROCHEMICALS: KEY BRANDS
• TABLE 44: GLYCOLS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 45: GLYCOLS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 46: POVIDONES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 47: MINERAL HYDROCARBONS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 48: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 49: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 50: OTHER PETROCHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 51: PROTEINS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 52: PROTEINS: KEY BRANDS
• TABLE 53: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 54: OTHER ORGANIC CHEMICALS: KEY BRANDS
• TABLE 55: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 56: INORGANIC CHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 57: INORGANIC CHEMICALS: KEY BRANDS
• TABLE 58: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 59: METAL OXIDES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 60: HALITES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 61: CALCIUM CARBONATE MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 62: CALCIUM SULFATE MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 63: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 64: OTHER CHEMICALS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 65: OTHER CHEMICALS: KEY BRANDS
• TABLE 66: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 67: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 68: EXCIPIENTS FOR FILLERS AND DILUENTS
• TABLE 69: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 70: EXCIPIENTS FOR SUSPENDING AND VISCOSITY AGENTS
• TABLE 71: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 72: EXCIPIENTS FOR COATING AGENTS
• TABLE 73: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 74: EXCIPIENTS FOR BINDERS
• TABLE 75: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 76: EXCIPIENTS FOR FLAVORING AGENTS
• TABLE 77: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 78: EXCIPIENTS FOR DISINTEGRANTS
• TABLE 79: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 80: EXCIPIENTS FOR COLORANTS
• TABLE 81: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 82: EXCIPIENTS FOR LUBRICANTS AND GLIDANTS
• TABLE 83: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 84: EXCIPIENTS FOR PRESERVATIVES
• TABLE 85: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 86: EXCIPIENTS FOR EMULSIFYING AGENTS
• TABLE 87: OTHER FUNCTIONALITIES MARKET, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
• TABLE 88: EXCIPIENTS FOR OTHER FUNCTIONALITIES
• TABLE 89: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 90: EXCIPIENTS FOR ORAL FORMULATIONS
• TABLE 91: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 92: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 93: TYPICAL COMPOSITION OF TABLETS
• TABLE 94: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 95: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 96: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 97: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD GELATIN CAPSULES, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 98: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT GELATIN CAPSULES, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 99: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 100: EXCIPIENTS FOR TOPICAL FORMULATIONS
• TABLE 101: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 102: TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
• TABLE 103: EXCIPIENTS USED IN PARENTERAL FORMULATIONS
• TABLE 104: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 105: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 106: PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2017-2025 (USD MILLION)
• TABLE 107: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 108: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 109: EUROPE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 110: EUROPE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 111: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 112: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017-2025 (USD MILLION)
• TABLE 113: GERMANY: KEY MICROINDICATORS
• TABLE 114: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 115: GERMANY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 116: GERMANY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 117: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 118: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017-2025 (USD MILLION)
• TABLE 119: FRANCE: KEY MICROINDICATORS
• TABLE 120: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 121: FRANCE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 122: FRANCE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 123: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 124: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017-2025 (USD MILLION)
• TABLE 125: UK: KEY MICROINDICATORS
• TABLE 126: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 127: UK: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 128: UK: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 129: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 130: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 131: SWITZERLAND: KEY MICROINDICATORS
• TABLE 132: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 133: SWITZERLAND: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 134: SWITZERLAND: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 135: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 136: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017-2025 (USD MILLION)
• TABLE 137: ITALY: KEY MICROINDICATORS
• TABLE 138: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 139: ITALY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 140: ITALY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 141: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 142: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017-2025 (USD MILLION)
• TABLE 143: SPAIN: KEY MICROINDICATORS
• TABLE 144: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 145: SPAIN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 146: SPAIN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 147: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 148: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 149: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 150: ROE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 151: ROE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 152: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 153: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 154: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 155: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 156: NORTH AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 157: NORTH AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 158: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 159: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 160: US: KEY MICROINDICATORS
• TABLE 161: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 162: US: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 163: US: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 164: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 165: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 166: CANADA: KEY MICROINDICATORS
• TABLE 167: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 168: CANADA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 169: CANADA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 170: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 171: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 172: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
• TABLE 173: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 174: ASIA PACIFIC: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 175: ASIA PACIFIC: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 176: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 177: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 178: JAPAN: KEY MICROINDICATORS
• TABLE 179: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 180: JAPAN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 181: JAPAN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 182: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 183: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 184: CHINA: KEY MICROINDICATORS
• TABLE 185: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 186: CHINA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 187: CHINA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 188: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 189: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 190: INDIA: KEY MICROINDICATORS
• TABLE 191: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 192: INDIA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 193: INDIA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 194: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 195: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 196: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 197: SOUTH KOREA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 198: SOUTH KOREA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 199: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 200: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 201: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 202: ROAPAC: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 203: ROAPAC: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 204: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 205: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 206: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 207: LATIN AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 208: LATIN AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 209: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 210: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 211: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
• TABLE 212: MIDDLE EAST AND AFRICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 213: MIDDLE EAST AND AFRICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017-2025 (USD MILLION)
• TABLE 214: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2025 (USD MILLION)
• TABLE 215: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017-2025 (USD MILLION)
• TABLE 216: PRODUCT LAUNCHES (2018-2019)
• TABLE 217: MERGERS AND ACQUISITIONS (2017-2019)
• TABLE 218: AGREEMENTS AND PARTNERSHIPS (2018-2019)
• TABLE 219: EXPANSIONS (2018-2019)
• TABLE 220: OTHER DEVELOPMENTS (2016-2018)

LIST OF FIGURES

• FIGURE 1: GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 2: RESEARCH DESIGN
• FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
• FIGURE 4: BOTTOM-UP APPROACH
• FIGURE 5: TOP-DOWN APPROACH
• FIGURE 6: DATA TRIANGULATION METHODOLOGY
• FIGURE 7: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019 VS. 2025 (USD MILLION)
• FIGURE 8: ORGANIC CHEMICALS MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION)
• FIGURE 9: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019 VS. 2025 (USD MILLION)
• FIGURE 10: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019 VS. 2025 (USD MILLION)
• FIGURE 11: GEOGRAPHICAL SNAPSHOT: PHARMACEUTICAL EXCIPIENTS MARKET
• FIGURE 12: GROWING PHARMACEUTICALS INDUSTRY COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS ARE KEY FACTORS DRIVING MARKET GROWTH
• FIGURE 13: ASIA PACIFIC IS PROJECTED TO SHOW THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
• FIGURE 14: EUROPE TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD (2018-2023)
• FIGURE 15: ORAL FORMULATION ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2018
• FIGURE 16: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
• FIGURE 17: PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
• FIGURE 18: GLOBAL PHARMACEUTICAL DRUG SALES (2008-2022)
• FIGURE 19: GROWTH OF THE GENERICS MARKET, 2006 VS 2016
• FIGURE 20: INCREASING PENETRATION OF ORPHAN DRUGS (2010-2024)
• FIGURE 21: RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US
• FIGURE 22: ESTIMATED PRE-APPROVAL COST OF BRINGING A NEW CHEMICAL OR BIOLOGICAL ENTITY TO MARKET (1970-2010)
• FIGURE 23: TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) & NEW BIOLOGIC LICENSE APPLICATION (BLA) FILINGS AND APPROVALS IN THE US, 2006-2018
• FIGURE 24: INCREASING FOCUS ON CO-PROCESSED EXCIPIENTS AND USE OF NANOTECHNOLOGY IN EXCIPIENT PRODUCTION ARE THE LEADING TRENDS IN THE INDUSTRY
• FIGURE 25: ORGANIC CHEMICALS SEGMENT TO DOMINATE THE PHARMACEUTICAL EXCIPIENTS MARKET IN 2019
• FIGURE 26: OLEOCHEMICALS ARE EXPECTED TO DOMINATE THE ORGANIC CHEMICALS MARKET DURING THE FORECAST PERIOD
• FIGURE 27: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019 VS. 2025
• FIGURE 28: ORAL FORMULATIONS TO FORM THE LARGEST SEGMENT IN THE PHARMACEUTICAL EXCIPIENTS MARKET DURING THE FORECAST PERIOD
• FIGURE 29: PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC SNAPSHOT
• FIGURE 30: EUROPE PHARMACEUTICAL PRODUCTION, 2015 VS. 2016 (USD BILLION)
• FIGURE 31: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
• FIGURE 32: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
• FIGURE 33: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
• FIGURE 34: KEY DEVELOPMENTS IN THE PHARMACEUTICAL EXCIPIENTS MARKET BETWEEN 2016 AND 2019
• FIGURE 35: GEOGRAPHICAL REVENUE MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2018)
• FIGURE 36: PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
• FIGURE 37: PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2018)
• FIGURE 38: R&D EXPENDITURE: MAJOR PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET 2017 & 2018
• FIGURE 39: DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT (2018)
• FIGURE 40: ROQUETTE FRERES: COMPANY SNAPSHOT (2017)
• FIGURE 41: ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT (2018)
• FIGURE 42: EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2018)
• FIGURE 43: BASF SE: COMPANY SNAPSHOT (2018)
• FIGURE 44: KERRY GROUP PLC: COMPANY SNAPSHOT (2018)
• FIGURE 45: CRODA INTERNATIONAL: COMPANY SNAPSHOT (2018)
• FIGURE 46: ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2018)
• FIGURE 47: ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT (2018)
• FIGURE 48: INNOPHOS HOLDINGS INC: COMPANY SNAPSHOT (2018)
• FIGURE 49: WACKER CHEMIE AG: COMPANY SNAPSHOT (2018)
• FIGURE 50: AIR LIQUIDE S.A.: COMPANY SNAPSHOT (2018)